Razelle Kurzrock, the director of the Center for Personalized Cancer Therapy at the Moores Cancer Center at UC San Diego, presents breakthroughs in genomics and targeted therapies that are being used in clinics and have the potential to revolutionize the practice of oncology. However, to realize that potential, Dr. Kurzrock argues that the old paradigms for treating patients and designing clinical trials must be replaced with approaches that target the abnormal genes in individual tumors and use advanced technological tools to match each patient with the best drug for his or her specific cancer. Dr. Kurzrock was presented by the Center for Ethics in Science and Technology in San Diego. (#25837)